{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:26:32Z","timestamp":1783437992898,"version":"3.54.6"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the doctoral research start-up fund of Nantong Tumor Hospital","award":["BS202113"],"award-info":[{"award-number":["BS202113"]}]},{"name":"Scientific research project of Nantong municipal health commission","award":["MSZ2023037"],"award-info":[{"award-number":["MSZ2023037"]}]},{"name":"Scientific research project of Nantong municipal health commission","award":["MSZ2023042"],"award-info":[{"award-number":["MSZ2023042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Radiosensitivity of rectal cancer is related to the radiotherapy efficacy and prognosis of patients with rectal cancer, and the genes and molecular mechanisms related to radiosensitivity of rectal cancer have not been clarified. We explored the radiosensitivity related genes of rectal cancer at a multi omics level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>mRNA expression data and rectum adenocarcinoma (READ) data were obtained from the Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus Database (GEO) (GSE150082, GSE60331, GSE46862, GSE46862). Differentially expressed genes between radiotherapy sensitive group and radiotherapy insensitive group were screened. GO analysis and KEGG pathway analysis were performed for differentially expressed genes. Among the differentially expressed genes, five core genes associated with rectal cancer prognosis were selected using random survival forest analysis. For these five core genes, drug sensitivity analysis, immune cell infiltration analysis, TISIDB database immune gene correlation analysis, GSEA enrichment analysis, construction of Nomogram prediction model, transcriptional regulatory network analysis, and qRT-PCR validation was performed on human rectal adenocarcinoma tissue.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that 600 up-regulated genes and 553 down-regulated genes were significantly different between radiotherapy sensitive group and radiotherapy insensitive group in rectal cancer. Five key genes, TOP2A, MATR3, APOL6, JOSD1, and HOXC6, were finally screened by random survival forest analysis. These five key genes were associated with different immune cell infiltration, immune-related genes, and chemosensitivity. A comprehensive transcriptional regulatory network was constructed based on these five core genes. qRT-PCR revealed that MATR3 expression was different in rectal cancer tissues and adjacent non-cancerous tissues, while APOL6, HOXC6, JOSD1, and TOP2A expression was not different.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Five radiosensitivity-related genes related to the prognosis of rectal cancer: TOP2A, MATR3, APOL6, JOSD1, HOXC6, are involved in multiple processes such as immune cell infiltration, immune-related genes, chemosensitivity, signaling pathways and transcriptional regulatory networks and may be potential biomarkers for radiotherapy of rectal cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04753-9","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T06:02:24Z","timestamp":1701064944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics"],"prefix":"10.1186","volume":"21","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomei","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-024X","authenticated-orcid":false,"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"key":"4753_CR1","first-page":"1109","volume-title":"Oncology Radiotherapy","author":"YX Li","year":"2018","unstructured":"Li YX, Wang LH, Gao L, et al. Oncology Radiotherapy. 5th ed. China Union Medical University Press; 2018. p. 1109\u201325.","edition":"5"},{"key":"4753_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.radonc.2020.09.026","volume":"154","author":"MA Gambacorta","year":"2021","unstructured":"Gambacorta MA, Masciocchi C, Chiloiro G, Meldolesi E, Macchia G, Vansoest J, Peters F, Collette L, Gerard JP, Ngan S, et al. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiother Oncol. 2021;154:154\u201360.","journal-title":"Radiother Oncol"},{"key":"4753_CR3","first-page":"126","volume-title":"Clinical Oncology Radiation Therapy","author":"W Kailiang","year":"2017","unstructured":"Kailiang W, Yan F, Chen XX, et al. Clinical Oncology Radiation Therapy. Fudan University Press; 2017. p. 126\u20138."},{"issue":"18","key":"4753_CR4","first-page":"1317","volume":"26","author":"H Chunyan","year":"2019","unstructured":"Chunyan H, Lijun S, Qingyun L. Mechanism and clinical research progress of radiotherapy combined with immunotherapy. Chin J Cancer Prev Treat. 2019;26(18):1317\u201322.","journal-title":"Chin J Cancer Prev Treat"},{"issue":"3","key":"4753_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.7150\/ntno.77564","volume":"7","author":"A Eftekhari","year":"2023","unstructured":"Eftekhari A, Kryschi C, Pamies D, Gulec S, Ahmadian E, Janas D, Davaran S, Khalilov R. Natural and synthetic nanovectors for cancer therapy. Nanotheranostics. 2023;7(3):236\u201357.","journal-title":"Nanotheranostics"},{"issue":"2","key":"4753_CR6","first-page":"103","volume":"5","author":"I Ahmadov","year":"2020","unstructured":"Ahmadov I, Bandaliyeva A, Nasibova A, Hasanova F, Khalilov R. The synthesis of the silver nanodrugs in the medicinal plant baikal skullcap (Scutellaria baicalensis georgi) and their antioxidant, antibacterial activity. Adv Biol Earth Sci. 2020;5(2):103\u201318.","journal-title":"Adv Biol Earth Sci"},{"issue":"1","key":"4753_CR7","first-page":"19","volume":"8","author":"G Binate","year":"2023","unstructured":"Binate G, Ganbarov K. Biological activity of chalcones as carbonyl compound derivatives. Adv Biol Earth Sci. 2023;8(1):19\u201326.","journal-title":"Adv Biol Earth Sci"},{"issue":"8","key":"4753_CR8","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/cancers12082227","volume":"12","author":"JM Sendoya","year":"2020","unstructured":"Sendoya JM, Iseas S, Coraglio M, Golubicki M, Robbio J, Salanova R, Kujaruk M, Mikolaitis V, Rizzolo M, Ruiz G, Cabanne A, Gualdrini U, Mendez G, Hirmas S, Rotondaro C, Viglino J, Eleta M, Fernandez E, Abba M, Podhajcer O, Roca E, Llera AS. Pre-existing tumoral B cell infiltration and impaired genome maintenance correlate with response to chemoradiotherapy in locally advanced rectal cancer. Cancers (Basel). 2020;12(8):2227.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"4753_CR9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/bjc.2015.93","volume":"112","author":"M Verstraete","year":"2015","unstructured":"Verstraete M, Debucquoy A, Dekervel J, van Pelt J, Verslype C, Devos E, Chiritescu G, Dumon K, D\u2019Hoore A, Gevaert O, Sagaert X, Van Cutsem E, Haustermans K. Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial. Br J Cancer. 2015;112(8):1314\u201325.","journal-title":"Br J Cancer"},{"key":"4753_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/1471-2105-9-307","volume":"9","author":"C Strobl","year":"2008","unstructured":"Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A. Conditional variable importance for random forests. BMC Bioinform. 2008;9:307.","journal-title":"BMC Bioinform"},{"issue":"5","key":"4753_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"6","key":"4753_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"key":"4753_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"4753_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4753_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9(9): e107468.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"4753_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0163-7258(89)90108-3","volume":"41","author":"N Osheroff","year":"1989","unstructured":"Osheroff N. Biochemical basis for the interactions of type I and type ii topoisomerases with DNA. Pharmacol Ther. 1989;41(1\u20132):223\u201341.","journal-title":"Pharmacol Ther"},{"key":"4753_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12935-019-0956-1","volume":"19","author":"W Ma","year":"2019","unstructured":"Ma W, Wang B, Zhang Y, Wang Z, Niu D, Chen S, et al. Prognostic signifificance of top2a in non-small cell lung cancer revealed by bioinformatic analysis. Cancer Cell Int. 2019;19:239.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"4753_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3892\/ol.2020.12095","volume":"20","author":"H Cai","year":"2020","unstructured":"Cai H, Shao B, Zhou Y, Chen Z. High expression of top2a in hepatocellular carcinoma is associated with disease progression and poor prognosis. Oncol Lett. 2020;20(5):232.","journal-title":"Oncol Lett"},{"issue":"2","key":"4753_CR19","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10549-012-2112-7","volume":"134","author":"JA Sparano","year":"2012","unstructured":"Sparano JA, Goldstein LJ, Davidson NE, Sledge GW Jr, Gray R. Top2a rna expression and recurrence in estrogen receptor-positive breast cancer. Breast Cancer Res Treat. 2012;134(2):751\u20137.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4753_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/ol.2020.12282","volume":"21","author":"J Li","year":"2021","unstructured":"Li J, Sun P, Huang T, He S, Li L, Xue G. Individualized chemotherapy guided by the expression of ercc1, rrm1, tubb3, tyms and top2a genes versus classic chemotherapy in the treatment of breast cancer: a comparative effectiveness study. Oncol Lett. 2021;21(1):21.","journal-title":"Oncol Lett"},{"issue":"4","key":"4753_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/sj.bjc.6604514","volume":"99","author":"SY Terry","year":"2008","unstructured":"Terry SY, Riches AC, Bryant PE. A role for topoisomerase ii alpha in the formation of radiation-induced chromatid breaks. Br J Cancer. 2008;99(4):670\u20134.","journal-title":"Br J Cancer"},{"issue":"7","key":"4753_CR22","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1158\/0008-5472.CAN-14-1924","volume":"75","author":"M Cojoc","year":"2015","unstructured":"Cojoc M, Peitzsch C, Kurth I, Trautmann F, Kunz-Schughart LA, Telegeev GD, et al. Aldehyde dehydrogenase is regulated by b-catenin\/tcf and promotes radioresistance in prostate cancer progenitor cells. Cancer Res. 2015;75(7):1482\u201394.","journal-title":"Cancer Res"},{"key":"4753_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.918959","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang H, Xue X, et al. TOP2A correlates with poor prognosis and affects radioresistance of Medulloblastoma. Front Oncol. 2022;12: 918959.","journal-title":"Front Oncol"},{"key":"4753_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40659-020-00310-6","volume":"53","author":"J Yang","year":"2020","unstructured":"Yang J, Lee SJ, Kwon Y, Ma L, Kim J. Tumor suppressive function of Matrin 3 in the basal-like breast cancer. Biol Res. 2020;53:42.","journal-title":"Biol Res"},{"key":"4753_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jdermsci.2020.08.013","volume":"100","author":"H Kuriyama","year":"2020","unstructured":"Kuriyama H, Fukushima S, Kimura T, et al. Matrin-3 plays an important role in cell cycle and apoptosis for survival in malignant melanoma. J Dermatol Sci. 2020;100:110\u20139.","journal-title":"J Dermatol Sci"},{"key":"4753_CR26","first-page":"333","volume":"41","author":"S-H Nho","year":"2019","unstructured":"Nho S-H, Yoon G, Seo J-H, et al. Licochalcone H induces the apoptosis of human oral squamous cell carcinoma cells via regulation of matrin 3. Oncol Rep. 2019;41:333.","journal-title":"Oncol Rep"},{"key":"4753_CR27","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00432-022-04097-9","volume":"148","author":"J Durslewicz","year":"2022","unstructured":"Durslewicz J, Klimaszewska-Wisniewska A, J\u00f3zwicki J, Antosik P, Kozerawski K, Grzanka D, Braun M. Prognostic signifificance of MATR3 in stage I and II non-small cell lung cancer patients. J Cancer Res Clin Oncol. 2022;148:3313\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4753_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbagrm.2015.02.003","volume":"1849","author":"I Hussain","year":"2015","unstructured":"Hussain I, Bhan A, Ansari KI, et al. Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer. Biochim Biophys Acta. 2015;1849:697\u2013708.","journal-title":"Biochim Biophys Acta"},{"key":"4753_CR29","first-page":"3281","volume":"20","author":"B Bodey","year":"2000","unstructured":"Bodey B, Bodey B Jr, Siegel SE, et al. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in breast carcinomas. Anticancer Res. 2000;20:3281\u20136.","journal-title":"Anticancer Res"},{"key":"4753_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1053\/j.gastro.2008.06.034","volume":"135","author":"K Fujiki","year":"2008","unstructured":"Fujiki K, Duerr EM, Kikuchi H, et al. Hoxc6 is overexpressed in gastrointestinal carcinoids and interacts with JunD to regulate tumor growth. Gastroenterology. 2008;135:907\u201316.","journal-title":"Gastroenterology"},{"key":"4753_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/sj.onc.1207906","volume":"24","author":"S Ramachandran","year":"2005","unstructured":"Ramachandran S, Liu P, Young AN, et al. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene. 2005;24:188\u201398.","journal-title":"Oncogene"},{"key":"4753_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jss.2014.01.017","volume":"188","author":"YB Du","year":"2014","unstructured":"Du YB, Dong B, Shen LY, et al. The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma. J Surg Res. 2014;188:442\u201350.","journal-title":"J Surg Res"},{"key":"4753_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.4149\/neo_2013_057","volume":"60","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Jin XS, Yang ZY, et al. Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients. Neoplasma. 2013;60:439\u201345.","journal-title":"Neoplasma"},{"issue":"1","key":"4753_CR34","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1080\/21691401.2019.1635136","volume":"47","author":"J Zhou","year":"2019","unstructured":"Zhou J, Yang X, Wang X, et al. HOXC6 in the prognosis of prostate cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):2715\u201320.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"4753_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.gene.2018.11.028","volume":"687","author":"Y Tan","year":"2019","unstructured":"Tan Y, Gan M, Fan Y, Li L, Zhong Z, Li X, Bai L, Zhao Y, Niu L, Shang Y, et al. miR-10b-5p regulates 3T3-L1 cells differentiation by targeting Apol6. Gene. 2019;687:39\u201346.","journal-title":"Gene"},{"key":"4753_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/biom13030415","volume":"13","author":"K Liu","year":"2023","unstructured":"Liu K, Chen Y, Zeng L, et al. Upregulation of apolipoprotein l6 improves tumor immunotherapy by inducing immunogenic cell death. Biomolecules. 2023;13:415.","journal-title":"Biomolecules"},{"key":"4753_CR37","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/cells10061341","volume":"10","author":"GR Raji","year":"2021","unstructured":"Raji GR, Poyyakkara A, Sameer Kumar VB, et al. Horizontal transfer of miR-643 from cisplatin-resistant cells confers chemoresistance to recipient drug-sensitive cells by targeting APOL6. Cells. 2021;10:1341.","journal-title":"Cells"},{"key":"4753_CR38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3389\/fphar.2020.01311","volume":"11","author":"C Zeng","year":"2020","unstructured":"Zeng C, Zhao C, Ge F, Li Y, Cao J, Ying M, Lu J, He Q, Yang B, Dai X, et al. Machado-Joseph deubiquitinases: from cellular functions to potential therapy targets. Front Pharmacol. 2020;11:1311.","journal-title":"Front Pharmacol"},{"issue":"11","key":"4753_CR39","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.bbamcr.2012.06.004","volume":"1823","author":"SJ Orcutt","year":"2012","unstructured":"Orcutt SJ, Wu J, Eddins MJ, Leach CA, Strickler JE. Bioluminescence assay platform for selective and sensitive detection of Ub\/Ubl proteases. Biochim BiophysActa. 2012;1823(11):2079\u201386.","journal-title":"Biochim BiophysActa"},{"issue":"1","key":"4753_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41418-019-0339-0","volume":"27","author":"X Wu","year":"2020","unstructured":"Wu X, Luo Q, Zhao P, Chang W, Wang Y, Shu T, Ding F, Li B, Liu Z. JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1. Cell Death Difer. 2020;27(1):55\u201370.","journal-title":"Cell Death Difer"},{"issue":"5","key":"4753_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/vim.2017.0015","volume":"30","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang L, Zhang Y, Zhao P, Qian L, Yuan Y, Liu J, Cheng Q, Xu W, Zuo Y, et al. JOSD1 negatively regulates type-i interferon antiviral activity by deubiquitinating and stabilizing SOCS1. Viral Immunol. 2017;30(5):342\u20139.","journal-title":"Viral Immunol"},{"key":"4753_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12935-021-02060-1","volume":"21","author":"C Jing","year":"2021","unstructured":"Jing C, Liu D, Duan Y, Wang X, et al. JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4. Cancer Cell Int. 2021;21:375.","journal-title":"Cancer Cell Int"},{"issue":"6349","key":"4753_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair defificiency predicts response of solid tumors to pd-1 blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science"},{"issue":"3","key":"4753_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/gut.48.3.360","volume":"48","author":"JM Michael-Robinson","year":"2001","unstructured":"Michael-Robinson JM, Biemer-Huttmann A, Purdie DM, Walsh MD, Simms LA, Biden KG, et al. Tumour infifiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratifified according to microsatellite instability status. Gut. 2001;48(3):360\u20136.","journal-title":"Gut"},{"issue":"23","key":"4753_CR45","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andre","year":"2020","unstructured":"Andre T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318.","journal-title":"N Engl J Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04753-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T06:02:37Z","timestamp":1701064957000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04753-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4753"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04753-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Nantong Tumor Hospital. The study\/research was performed in accordance with the Declaration of Helsinki and all methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"856"}}